Dublin, Nov. 27, 2023 (GLOBE NEWSWIRE) — The “Respiratory Disease Testing Market Size, Share & Trends Analysis Report By Product (Imaging Tests, Respirometers, Blood Gas Tests), By End-use, By Application, By Region, And Segment Forecasts, 2023 – 2030” report has been added to ResearchAndMarkets.com’s offering.
The global respiratory disease testing market size is expected to reach USD 7.75 billion by 2030, registering a CAGR of 2.8% from 2023 to 2030
The market is driven by the rising prevalence of respiratory diseases. As per Forum of International Respiratory Societies, more than 200 million people across the globe suffered from Chronic Obstructive Pulmonary Disease (COPD) and 235 million suffered from asthma in 2014. In addition, the source stated that more than 50 million people struggle with occupational lung diseases annually. Thus, constantly growing target patient population is anticipated to drive the growth.
The adoption of innovative technologies, such as Computed Tomography (CT), for COPD diagnosis is expected to drive the growth. The other new technology in acute medical management of COPD is pulse oximeter that is used for outpatient monitoring. Airway management plays a main role in testing and management of COPD.
Also, with recent technological innovations, there has been a 12.1 % increase in the use of Noninvasive Mechanical Ventilation (NIV) for management of COPD. Along with technological advancements, use of digital radiography (X-ray) and advanced portable spirometers is gaining momentum in the respiratory disease testing/diagnostics market.
Respiratory Disease Testing Market Report Highlights
- Growing prevalence of respiratory diseases and rapid technological advancements are two of the major factors expected to propel the market growth
- Based on products, imaging tests held the largest share in 2022 due to rapid development and adoption of innovative technologies
- Based on application, tuberculosis was the largest market in 2022 owing to rising prevalence of the disease globally
- Based on end-use, hospitals segment held the largest share in 2022 and is anticipated to grow over the forecast period due to an increase in hospitalization and a growing preference for hospital treatment
- North America dominated the respiratory disease testing market in 2022. Growing prevalence of respiratory diseases such as COPD, & asthma, increasing demand for early diagnosis, and rising awareness amongst patients about the benefits of early diagnosis are responsible for the dominance
- Asia Pacific region is expected to grow at the fastest rate during the forecast period. This growth can be attributed to various factors, such as improving healthcare infrastructure and increasing patient awareness regarding the availability of new diagnostic techniques for respiratory diseases, such as COPD & asthma
- Some of the major players competing in this market include, but are not limited to, Becton Dickinson (Carefusion Corporation); Koninklijke Philips N.V. (Respironics); ResMed Company; Fischer & Paykel; and Medtronic. These players are strong brands in the market as they have elaborate product portfolios in respiratory disease diagnostics market
Company Profiles
- Abbott
- BD
- Koninklijke Philips N.V.
- ResMed
- Fisher & Paykel Appliances Ltd
- Medtronic
- BIOMERIEUX
- Carestream Health
- SDI Diagnostics
- Siemens Healthcare GmbH
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 90 |
| Forecast Period | 2022 – 2030 |
| Estimated Market Value (USD) in 2022 | $6.18 Billion |
| Forecasted Market Value (USD) by 2030 | $7.75 Billion |
| Compound Annual Growth Rate | 2.8% |
| Regions Covered | Global |
Key Topics Covered:
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End-use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Respiratory Disease Testing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Respiratory Disease Testing Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.2. PESTEL Analysis
Chapter 4. Respiratory Disease Testing: Product Estimates & Trend Analysis
4.1. Respiratory Disease Testing Market: Key Takeaways
4.2. Respiratory Disease Testing Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Imaging Tests
4.3.1. Imaging tests market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Respiratory Measurement devices
4.5. Blood Gas Test
Chapter 5. Respiratory Disease Testing: Application Estimates & Trend Analysis
5.1. Respiratory Disease Testing Market: Key Takeaways
5.2. Respiratory Disease Testing Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Chronic Obstructive Pulmonary Disease
5.3.1. Chronic obstructive pulmonary disease market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Lung Cancer
5.5. Asthma
5.6. Tuberculosis
Chapter 6. Respiratory Disease Testing: End-use Estimates & Trend Analysis
6.1. Respiratory Disease Testing Market: Key Takeaways
6.2. Respiratory Disease Testing Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Hospital
6.4. Physicians Clinic
6.5. Clinical Laboratories
Chapter 7. Respiratory Disease Testing Market: Regional Estimates & Trend Analysis
7.1. Regional Outlook
7.2. Respiratory Disease Testing Market by Region: Key Marketplace Takeaway
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Market Participant Categorization
For more information about this report visit https://www.researchandmarkets.com/r/86jwft
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Global Respiratory Disease Testing Market
